SUVENPHAR Suven Pharmaceuticals Ltd Company Mergers Announcement 2025 - Share Allotment On May 9, 2025, Suven Pharmaceuticals allotted 12,80,02,184 equity shares at a ratio of 11:295 under the Scheme of Amalgamation with Cohance Lifesciences, as approved by NCLT on March 27, 2025..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd